(1 - 8 von 11
)
Oncology Ventures CEO Peter Buhl Jensen buys shares in the
www.globenewswire.com
Company Announcement Oncology Ventures CEO Peter Buhl Jensen buys shares in the Company Hoersholm, Denmark – December 6, – Oncology Venture A/S...
A match made in Scandinavia - European Biotechnology
european-biotechnology.com
„When I entered the company in as a CEO it seemed to me like a rational model to use MPI's drug response predictor (DRP) technology for developing a propriertary cancer drug pipeline and benefit from the full value the DRP can add a drug,” Peter Buhl Jensen told EuroBiotech. The result was a spin-off dubbed Oncology Venture.
sortiert nach Relevanz / Datum